What’s in a name. A confusing decade of trying to explain our own brand, what category of company we were, and what exactly we offered — program, service, infrastructure, or real estate. The real challenge wasn’t the work itself. It was building a new industry vertical faster than anyone could name it.

I set out to solve inefficiencies in drug development and somehow became a global expert on lab design and real estate. This is the story of how that happened, and why it made sense in the end.

At Taiwan’s national CDMO summit, Amrit Chaudhuri delivered a keynote address on the global state of the contract development and manufacturing industry — analyzing its evolution, consolidation, and geopolitical dynamics.

In this interview, he joins FierceBiotech’s Rebecca Williamson about the major disruption the sector is going through, and where he sees the next chapter unfolding.

SmartLabs was featured at the Cell & Gene Meeting on the Mesa, discussing how platformized infrastructure is accelerating advanced therapy development.

How SmartLabs’ Universal Lab Framework creates adaptable labs and streamlined operations for biopharma teams.

Coverage from Yahoo Finance and The BioStartups detailing SmartLabs’ 2023 strategic roadmap—the evolution of its end-to-end R&D support model and the expansion of its digital and physical infrastructure network.

Ben Kaplan dives deep into the world of lab infrastructure and innovation with Amrit Chaudhuri.

SmartLabs plans to convert the third floor of the CambridgeSide Mall into state-of-the-art lab space by late 2024.

SmartLabs has leased the entire third floor of the CambridgeSide Mall for a new managed research center.